Induction of T lymphocyte responses to dengue virus by a candidate tetravalent live attenuated dengue virus vaccine
Authors:
- 1 September 2001
- Vol. 19 (32) , 4694-4699
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteersVaccine, 2001
- Dengue and dengue haemorrhagic feverThe Lancet, 1998
- Risk Factors in Dengue Shock SyndromeThe American Journal of Tropical Medicine and Hygiene, 1997
- Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a.Journal of Clinical Investigation, 1996
- Dengue Virus-Specific Memory T Cell Responses in Human Volunteers Receiving a Live Attenuated Dengue Virus Type 2 Candidate VaccineThe Journal of Infectious Diseases, 1994
- Dengue virus-specific human CD4+ T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determinationJournal of Virology, 1993
- Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production.Journal of Clinical Investigation, 1989
- Virulence of a Live Dengue Virus Vaccine Candidate: A Possible New Marker of Dengue Virus AttenuationThe Journal of Infectious Diseases, 1988
- A Prospective Study of Dengue Infections in BangkokThe American Journal of Tropical Medicine and Hygiene, 1988
- Dengue 2 Vaccine: Dose Response in Volunteers in Relation to Yellow Fever Immune StatusThe Journal of Infectious Diseases, 1983